On 2025-05-12, Dianthus Therapeutics, Inc. (DNTH) announced earnings per share of $-0.82 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-0.86.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.86 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-12 | 2025-03-31 | $-0.86 | $-0.82 |
| 2025-03-11 | 2024-12-31 | $-0.85 | $-0.81 |
| 2024-11-07 | 2024-09-30 | $-0.59 | $-0.74 |
| 2024-08-08 | 2024-06-30 | $-0.50 | $-0.51 |
| 2024-05-09 | 2024-03-31 | $-0.43 | $-0.54 |
| 2024-03-21 | 2023-12-31 | $-1.11 | $-0.71 |
| 2023-11-09 | 2023-09-30 | $-0.51 | $-3.78 |
| 2023-08-03 | 2023-06-30 | $-3.04 | $-0.80 |
| 2022-11-03 | 2022-09-30 | $-4.96 | $-4.32 |
| 2022-08-04 | 2022-06-30 | $-5.92 | $-4.64 |
| 2022-05-16 | 2022-03-31 | $-5.44 | $-6.24 |
| 2022-03-08 | 2021-12-31 | $-5.12 | $-5.28 |
| 2021-11-04 | 2021-09-30 | $-5.12 | $-4.80 |
| 2021-08-05 | 2021-06-30 | $-5.60 | $-5.12 |
| 2021-05-06 | 2021-03-31 | $-6.40 | $-5.76 |
| 2021-03-03 | 2020-12-31 | $-6.88 | $-6.08 |
| 2020-11-05 | 2020-09-30 | $-7.20 | $-5.92 |
| 2020-08-06 | 2020-06-30 | $-8.48 | $-7.68 |
| 2020-05-07 | 2020-03-31 | $-9.76 | $-8.16 |
| 2020-03-03 | 2019-12-31 | $-9.28 | $-9.44 |
| 2019-11-13 | 2019-09-30 | $-8.48 | $-8.64 |
| 2019-08-08 | 2019-06-30 | $-7.84 | $-7.68 |
| 2019-05-09 | 2019-03-31 | $-8.48 | $-7.04 |
| 2019-03-19 | 2018-12-31 | -- | $-8.00 |
| 2018-11-08 | 2018-09-30 | $-7.36 | $-7.84 |
| 2018-08-09 | 2018-06-30 | $-15.52 | $-50.08 |